Compare · CME vs YIN
CME vs YIN
Side-by-side comparison of CME Group Inc. (CME) and Yintech Investment Holdings Limited (YIN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CME and YIN operate in Investment Bankers/Brokers/Service (Finance), so they compete in similar markets.
- CME carries a market cap of $91.33B.
- CME has hit the wire 10 times in the past 4 weeks while YIN has been quiet.
- CME has more recent analyst coverage (25 ratings vs 0 for YIN).
CME Group Inc.
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products through its electronic trading platforms, open outcry, and privately negotiated transactions. The company also provides clearing for exchange-traded contracts and cleared swaps, as well as settlement services; and transaction lifecycle management services, such as trade and portfolio management, financial resource optimization, regulatory reporting, and trade processing. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company has strategic partnership with B3 S.A. to develop risk management products for Brazilian domestic and international market participants. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.
Latest CME
- CME Group Announces First Trades for New Bitcoin Volatility Futures
- CME Group downgraded by Erste Group
- CME Group May Volume Hits New Record of 33.2 Million Contracts, Up 15% Year Over Year
- CME Group Announces Launch of 24/7 Cryptocurrency Futures and Options Trading
- CME Group Chairman and Chief Executive Officer Terry Duffy to Present at Piper Sandler Global Exchange and Fintech Conference
- CME Group Awards Star Scholarships to Chicago Students Pursuing Four-Year Degrees
- SEC Form DEFA14A filed by CME Group Inc.
- Sr MD & Chief HR Officer Piell Hilda Harris sold $1,752,536 worth of Common Stock Class A (5,753 units at $304.63), decreasing direct ownership by 17% to 27,702 units (SEC Form 4)
- CME Group Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Chairman and CEO Duffy Terrence A sold $10,447,866 worth of Common Stock Class A (35,000 units at $298.51), decreasing direct ownership by 39% to 55,630 units (SEC Form 4)
Latest YIN
- Yintech Announces Completion of Going Private Transaction
- Lifshitz Law Firm, P.C. Announces Investigation of American Renal Associates Holdings, Inc., BMC Stock Holdings, Inc., Callaway Golf Company, Cellular Biomedicine Group, Inc., CIT Group Inc., Eidos Therapeutics, Inc., Watford Holdings Ltd. and Yintech Investment Holdings Limited
- Lifshitz Law Firm, P.C. Announces Investigation of American Renal Associates Holdings, Inc., BMC Stock Holdings, Inc., Builders FirstSource, Inc., Cellular Biomedicine Group, Inc., CIT Group Inc., Eidos Therapeutics, Inc., MyoKardia, Inc. Watford Holdings Ltd. and Yintech Investment Holdings Limited
- INVESTIGATION ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm - MVC, ARA, YIN, MYOS
- Lifshitz Law Firm, P.C. Announces Investigation of American Renal Associates Holdings, Inc. (NYSE: ARA), BMC Stock Holdings, Inc., Builders FirstSource, Inc., Cancer Genetics, Inc., Cellular Biomedicine Group, Inc., Eidos Therapeutics, Inc., Montage Resources Corporation, MyoKardia, Inc. and Yintech Investment Holdings Limited
- Departure of an Independent Director
- IMPORTANT SHAREHOLDER ALERT: Halper Sadeh LLP Reminds Shareholders About Its Ongoing Investigations; Investors are Encouraged to Contact the Firm - CGIX, YIN, OTEL, BMCH
- Lifshitz Law Firm, P.C. Announces Investigation of Akcea Therapeutics, Inc. (NASDAQ: AKCA), BMC Stock Holdings, Inc. (NASDAQ: BMCH), Builders FirstSource, Inc. (NASDAQ: BLDR), Cancer Genetics, Inc. (NASDAQ: CGIX), Cellular Biomedicine Group, Inc. (NASDAQ: CBMG), Otelco Inc. (NASDAQ: OTEL), Rosetta Stone Inc. (NYSE: RST), Varian Medical Systems, Inc. (NYSE: VAR), and Yintech Investment Holdings Limited (NASDAQ: YIN)
- Lifshitz Law Firm, P.C. Announces Investigation of Pfenex Inc. (NYSE: PFNX), Proteostasis Therapeutics, Inc. (NASDAQ: PTI), Rosetta Stone Inc. (NYSE:RST) and Yintech Investment Holdings Limited (NASDAQ: YIN)
- INVESTIGATION ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm – YIN, BLDR, PTI, CGIX